We are live on
!
Find out more
BBA
Baker Bros. Advisors Portfolio holdings
AUM
$17.4B
1-Year Est. Return
131.5%
This Fund
S&P 500
This Quarter
Est. Return
+2.27%
1 Year Est. Return
+131.5%
3 Year Est. Return
+336.81%
5 Year Est. Return
+553.16%
10 Year Est. Return
+4,134.93%
AUM
$17.4B
AUM Growth
+$337M
(+2%)
Cap. Flow
+$511M
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
73.49%
Holding
93
New
8
Increased
18
Reduced
6
Closed
9
Top Buys
| 1 |
Praxis Precision Medicines
PRAX
|
+$194M |
| 2 |
GRAL
GRAIL Inc
GRAL
|
+$151M |
| 3 |
Insmed
INSM
|
+$127M |
| 4 |
Mirum Pharmaceuticals
MIRM
|
+$42M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
+$31.4M |
Top Sells
| 1 |
Ultragenyx Pharmaceutical
RARE
|
+$63.8M |
| 2 |
Immunocore
IMCR
|
+$51.4M |
| 3 |
TERN
Terns Pharmaceuticals
TERN
|
+$38.4M |
| 4 |
BioNTech
BNTX
|
+$25.6M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$22M |
Sector Composition
| 1 | Healthcare | 99.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Neurogene
NGNE
$772M
| $20M | 0.11% |
991,691
| – | – |
|
|
EVMN
52
Evommune Inc
EVMN
$445M
| $19.5M | 0.11% |
+847,390
| New | +$19.2M |
|
|
TECX
53
Tectonic Therapeutic
TECX
$663M
| $18.8M | 0.11% |
607,788
-295,612
| -33% | -$7.27M |
|
|
CTNM
54
Contineum Therapeutics
CTNM
$554M
| $18.6M | 0.11% |
1,420,838
| – | – |
|
55
argenx
ARGX
$54.4B
| $18.4M | 0.11% |
25,174
| – | – |
|
56
Cerus
CERS
$609M
| $18.2M | 0.1% |
10,008,345
| – | – |
|
57
Taysha Gene Therapies
TSHA
$1.67B
| $17.9M | 0.1% |
4,004,756
| – | – |
|
|
AKTS
58
Aktis Oncology
AKTS
$1.43B
| $17.8M | 0.1% |
+996,351
| New | +$19.3M |
|
|
GENB
59
Generate Biomedicines
GENB
$1.83B
| $17.8M | 0.1% |
+1,423,602
| New | +$17.4M |
|
|
SION
60
Sionna Therapeutics
SION
$2.01B
| $16M | 0.09% |
400,000
| – | – |
|
61
Dyne Therapeutics
DYN
$3.96B
| $14.7M | 0.08% |
813,449
| – | – |
|
62
Xencor
XNCR
$1.1B
| $13.3M | 0.08% |
1,102,106
| – | – |
|
|
CMPS
63
Compass Pathways
CMPS
$1.81B
| $13M | 0.07% |
+2,344,720
| New | +$15.8M |
|
64
Relay Therapeutics
RLAY
$4.12B
| $11.5M | 0.07% |
1,160,117
| – | – |
|
65
Sera Prognostics
SERA
$77.1M
| $11.2M | 0.06% |
5,498,170
| – | – |
|
|
66
BioNTech
BNTX
$22.9B
| $10.6M | 0.06% |
119,743
-249,180
| -68% | -$25.6M |
|
67
Pharvaris
PHVS
$2.4B
| $10.6M | 0.06% |
375,000
| – | – |
|
68
Arcus Biosciences
RCUS
$3.55B
| $8.98M | 0.05% |
415,621
+145,621
| +54% | +$3.14M |
|
|
MPLT
69
MapLight Therapeutics
MPLT
$1.69B
| $7.41M | 0.04% |
364,705
| – | – |
|
70
Absci
ABSI
$1.75B
| $6.4M | 0.04% |
2,134,803
| – | – |
|
71
Wave Life Sciences
WVE
$1.18B
| $5.96M | 0.03% |
822,638
+478,575
| +139% | +$6.23M |
|
72
vTv Therapeutics
VTVT
$126M
| $5.88M | 0.03% |
148,314
| – | – |
|
|
EIKN
73
Eikon Therapeutics
EIKN
$557M
| $5.88M | 0.03% |
+555,555
| New | +$7.43M |
|
74
Protara Therapeutics
TARA
$234M
| $5.06M | 0.03% |
971,614
| – | – |
|
75
Sagimet Biosciences
SGMT
$473M
| $4.98M | 0.03% |
952,996
| – | – |
|
Similar funds
MCM
ASRS
PP
CS
SFA
VMPIC
LA
BCIM